AG
Arvind Gupta
Partner at Mayfield
San Francisco, California
Overview
Arvind Gupta is a Partner at Mayfield Fund and the Founder of IndieBio, with a strong background in investing in startups across various sectors such as ClimateTech, BioTech, and Web3/Crypto. He has invested in notable companies like Windfall Bio and Prellis Biologics, showcasing his expertise in identifying and supporting innovative ventures.
Arvind Gupta's career highlights include founding IndieBio, a leading biotech accelerator, and his role as a Partner at Mayfield Fund, where he has made impactful investments in companies like Geltor and Stämm Biotech.
Work Experience
Partner
2020 - Current
Mayfield is an early-stage VC firm investing in enterprise, deeptech, and human and planetary health companies.
Founder
2013
Venture Advisor at IndieBio
2020
Board Member
2017 - 2021
Board Member
2019 - 2020
New Culture is a food and beverage company that focuses on revolutionizing how cheese is made.
Raised $28,500,000.00 from CJ CheilJedang Corp..
Board Member
2018 - 2020
Board Member
2016 - 2020
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Raised $11,575,000.00 from Bristol-Myers Squibb.
Board Member
2014 - 2020
General Partner, Founder IndieBio
2013 - 2020
SOSV is a deep tech venture firm that invests from a startup's inception and operates the HAX and IndieBio programs.
Co-Founder
2011 - 2015
Design Director - Product Design and Strategy
2011 - 2013
Senior Portfolio Lead for IDEO Asia, IDEO Bay Area
2008 - 2011
Project Leader
2005 - 2008
Senior Industrial Designer
2003 - 2005
Education
BS
1992 - 1997